Table 2 Clinicopathological features of GATA3 negative breast cancers
Nottingham grade | Low-grade (Grade 1 and Grade 2) | High-grade (Grade 3) | ||||
|---|---|---|---|---|---|---|
Gata-3 expression | Negative | Positive | P-value | Negative | Positive | P-value |
Agea (N) | 69 ± 6.7 (7) | 64 ± 1.1 (152) | 0.3550 | 57 ± 1.8 (54) | 62 ± 1.4 (142) | 0.0732 |
Nottingham Grade | <0.0001 | |||||
1 | 1 (2%) | 47 (98%) | ||||
2 | 6 (5%) | 105 (95%) | ||||
3 | 54 (28%) | 142 (72%) | ||||
pT stage | 0.4673 | 0.2223 | ||||
1 | 4 (3%) | 112 (97%) | 31 (32%) | 67 (69%) | ||
2 | 3 (9%) | 31 (91%) | 15 (21%) | 58 (79%) | ||
3 | 0 | 5 (100%) | 6 (40%) | 9 (60%) | ||
4 | 0 | 4 (100%) | 1 (14%) | 6 (86%) | ||
pN stage | 0.4247 | 0.2580 | ||||
0 | 3 (3%) | 93 (97%) | 32 (32%) | 66 (67%) | ||
1 | 1 (3%) | 33 (97%) | 10 (20%) | 40 (80%) | ||
2 | 1 (17%) | 5 (83%) | 2 (17%) | 10 (83%) | ||
3 | 0 | 5 (100%) | 0 | 5 (100%) | ||
X | 2 (11%) | 16 (89%) | 9 (33%) | 18 (67%) | ||
pM stage | 0.6172 | 0.9294 | ||||
0 | 5 (5%) | 106 (95%) | 36 (28%) | 91 (72%) | ||
1 | 0 | 0 | 1 (33%) | 2 (67%) | ||
x | 2 (8%) | 24 (92%) | 12 (31%) | 51 (69%) | ||
Chemo/radiation Therapy | 0.2952 | 0.2785 | ||||
Yes | 4 (4%) | 103 (96%) | 39 (29%) | 94 (71%) | ||
No | 3 (8%) | 33 (91%) | 10 (21%) | 37 (79%) | ||